ODS

Trethera Announces FDA Orphan Drug Designation Granted to TRE-515 in the Treatment of Acute Disseminated Encephalomyelitis

Retrieved on: 
Tuesday, August 30, 2022
Inflammation, ADEM, Cancer, Autoimmune disease, Research, Degenerative disease, Central nervous system, Regulation of food and dietary supplements by the U.S. Food and Drug Administration, Brain, Deoxycytidine kinase, Cranial nerves, Death, Multiple sclerosis, DCK, Acute disseminated encephalomyelitis, Mouse, Food, DNA, Orphan drug, GLOBE, Company, FDA, ODS, UCLA, COVID-19, Spinal cord, Marketing, Private Securities Litigation Reform Act, Patient, Pharmaceutical industry

LOS ANGELES, Aug. 30, 2022 (GLOBE NEWSWIRE) -- Trethera Corporation (Trethera), a biopharmaceutical company committed to developing novel drugs targeting nucleotide metabolism for the treatment of cancer and autoimmune diseases, announced that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Status (ODS) to TRE-515, Tretheras first-in-class drug for the treatment of acute disseminated encephalomyelitis (ADEM).

Key Points: 
  • LOS ANGELES, Aug. 30, 2022 (GLOBE NEWSWIRE) -- Trethera Corporation (Trethera), a biopharmaceutical company committed to developing novel drugs targeting nucleotide metabolism for the treatment of cancer and autoimmune diseases, announced that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Status (ODS) to TRE-515, Tretheras first-in-class drug for the treatment of acute disseminated encephalomyelitis (ADEM).
  • No medications have been specifically approved by the FDA to treat it, said Dr. Peter Clark, a specialist member of the Trethera Scientific Advisory Board.
  • The ODS designation qualifies Trethera for certain incentives, which include FDA assistance in designing clinical trials, access to the FDA Orphan Drug Grants Program, exemption from the drug approval application fee and eligibility for seven years of marketing exclusivity.
  • Trethera's innovative approach to targeting nucleotide metabolism led to the development of TRE-515, an orally taken capsule twice designated by the FDA as an Orphan Drug.

Laser Tracker Market worth $866 million by 2027 - Exclusive Report by MarketsandMarkets™

Retrieved on: 
Wednesday, August 17, 2022
Knowledge, 3D Systems, Intelligence, SME, Industry, Robotics, Growth, Software, Car, Hardware, Efficiency, Research, Columbia Manufacturing Inc., Reverse engineering, GEM, CAGR, VMM, Quality control, BMW, VMT, Hexagon, Hexagon AB, Simulation, Laser, CMM, ODS, Motor vehicle, USD, Adoption, Mobile phone, Risk management, 3D printing, Medical imaging, Marketing, Geography, Technology, Solution

The growth of the laser tracker market can be attributed to increased adoption of robotics along with laser trackers in developed countries.

Key Points: 
  • The growth of the laser tracker market can be attributed to increased adoption of robotics along with laser trackers in developed countries.
  • Quality control and inspection to hold largest share of laser tracker market during the forecast period.
  • Laser tracker market for automotive industry is expected to grow at the highest CAGR during the forecast period.
  • Laser tracker market in Europe is expected to hold the second largest size during the forecast period.

Laser Tracker Market worth $866 million by 2027 - Exclusive Report by MarketsandMarkets™

Retrieved on: 
Wednesday, August 17, 2022
Knowledge, 3D Systems, Intelligence, SME, Industry, Robotics, Growth, Software, Car, Hardware, Efficiency, Research, Columbia Manufacturing Inc., Reverse engineering, GEM, CAGR, VMM, Quality control, BMW, VMT, Hexagon, Hexagon AB, Simulation, Laser, CMM, ODS, Motor vehicle, USD, Adoption, Mobile phone, Risk management, 3D printing, Medical imaging, Marketing, Geography, Technology, Solution

The growth of the laser tracker market can be attributed to increased adoption of robotics along with laser trackers in developed countries.

Key Points: 
  • The growth of the laser tracker market can be attributed to increased adoption of robotics along with laser trackers in developed countries.
  • Quality control and inspection to hold largest share of laser tracker market during the forecast period.
  • Laser tracker market for automotive industry is expected to grow at the highest CAGR during the forecast period.
  • Laser tracker market in Europe is expected to hold the second largest size during the forecast period.

Instructure's Elevate Earns Ed-Fi Rebadging, Validating its Commitment to Secure, Connected Data for Schools

Retrieved on: 
Wednesday, August 10, 2022
Movement, API, Access, U.S. Securities and Exchange Commission, Risk, Analytics, Physical security information management, Forward-looking statement, NYSE, Student, Private Securities Litigation Reform Act, Technology, SEC, Information, Security (finance), Software as a service, Company, School, Education, Form 10-K, Parent, Overload, Partnership, Elevate, LMS, SALT, Solution, Annual report, ODS, Medicine, Tutoring, Instructure, Canvas

SALT LAKE CITY, Aug. 10, 2022 /PRNewswire/ -- Instructure, the maker of Canvas, today announced it has earned a renewed Ed-Fi Managed Operational Data Store and API Platform Badge for Elevate K-12 Analytics and the Ed-Fi API Provider Badge for Elevate Standards Alignment (formerly Academic Benchmarks), both for another two years. The distinction validates Instructure as an ongoing, trusted Ed-Fi Operational Data Store, Analytics provider and API partner.

Key Points: 
  • The distinction validates Instructure as an ongoing, trusted Ed-Fi Operational Data Store, Analytics provider and API partner.
  • Districts have hundreds of applications in use and typically this data remains siloed and unused.
  • By seamlessly and securely bringing these data sources together through a data standard; administrators, educators and parents can more clearly see important data in real-time to support student success.
  • These badges demonstrate Instructure's continued commitment to openness and interoperability with the products that comprise the Instructure Learning Platform .

Trethera Announces FDA Orphan Drug Designation Granted to TRE-515 for the Treatment of Demyelinating Optic Neuritis

Retrieved on: 
Tuesday, August 9, 2022
FDA, Death, Regulation of food and dietary supplements by the U.S. Food and Drug Administration, Mouse, Inflammation, CEO, MS, GLOBE, Private Securities Litigation Reform Act, Cancer, UCLA, Optic neuritis, ADEM, Disease, Research, CNS demyelinating autoimmune diseases, Pain, Steroid, Marketing, Patient, Deoxycytidine kinase, DNA, Multiple sclerosis, Company, Orphan drug, Autoimmune disease, Severe cognitive impairment, Central nervous system, ODS, DCK, COVID-19, Optic nerve, Degenerative disease, Food, Immune system, Association, Acute disseminated encephalomyelitis, Pharmaceutical industry, Medical device

LOS ANGELES, Aug. 09, 2022 (GLOBE NEWSWIRE) -- Trethera Corporation (Trethera), a clinical stage biopharmaceutical company committed to developing novel drugs targeting nucleotide metabolism for the treatment of cancer and autoimmune diseases, announced that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Status (ODS) to TRE-515 for the treatment of optic neuritis (ON).

Key Points: 
  • LOS ANGELES, Aug. 09, 2022 (GLOBE NEWSWIRE) -- Trethera Corporation (Trethera), a clinical stage biopharmaceutical company committed to developing novel drugs targeting nucleotide metabolism for the treatment of cancer and autoimmune diseases, announced that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Status (ODS) to TRE-515 for the treatment of optic neuritis (ON).
  • TRE-515 is developing an impressive resume for potential treatments of demyelinating autoimmune diseases.
  • The ODS designation qualifies Trethera for certain incentives, which include FDA assistance in designing clinical trials, access to the FDA Orphan Drug Grants Program, exemption from the drug approval application fee and eligibility for seven years of marketing exclusivity.
  • Trethera's innovative approach to targeting nucleotide metabolism led to the development of TRE-515, an orally taken capsule twice designated by the FDA as an Orphan Drug.

Eliminating The Primary Cause of Bearing Failure, Greaseless Cam Followers Rise to the Occasion in Robotics Applications

Retrieved on: 
Monday, August 1, 2022
Motion, Food, Intech, Wi-Fi, Maintenance, Aluminium, Rotation, Polymer, ODS, Robotics, Lubrication, Stainless steel, Life, Vibration, ICAM, Automation, Materials Studio, Noise, Printed circuit board, Forging

CLOSTER, N.J., July 31, 2022 /PRNewswire-PRWeb/ -- Its common to run into issues trying to select small cam followers for an application. Certain design constraints may be limiting the available choices. There may be pressing questions like might be asking questions like: "Can the cam followers be easily accessed for lubrication?" or "Will metal cam followers wear out aluminum rails?" But most common is "will they stand up to washdown and if so for how long.?"

Key Points: 
  • Intech Corporation, known for its patented high load non-lubricated cam followers, introduces new miniature cam followers to meet the demanding needs of robotic applications.
  • Designed to eliminate the root cause of most bearing failures, insufficient lubrication, greaseless cam followers can increase a robots uptime and reduce its maintenance expense.
  • There may be pressing questions like might be asking questions like: "Can the cam followers be easily accessed for lubrication?"
  • By avoiding this frequent source of contamination, iCam cam followers and guide rollers are an excellent replacement for metal cam followers in food, beverage and pharmaceutical applications.

Performant Capital Creates Platform Delivering Managed Technology Services and Revenue Cycle Management to the Healthcare Industry

Retrieved on: 
Friday, July 29, 2022
Professional Services, Health, Technology, Software, Finance, Asset Management, General Health, Acquisition, GS, Goldman Sachs, Investment, Capital, Physician, RCM, Health, NYSE, Partnership, Solution, Software, EMS, IBM Application Performance Management, Hospital medicine, Technology, Organization, DBS, AA, Software as a service, LLC, Private credit, Growth, ODS, ID, Risk management, Security (finance), Ophthalmology

Provider Technology is a leading technology provider of outsourced software and IT services, revenue cycle management (RCM) and back-office business support primarily to physician practices and health systems.

Key Points: 
  • Provider Technology is a leading technology provider of outsourced software and IT services, revenue cycle management (RCM) and back-office business support primarily to physician practices and health systems.
  • The Private Credit business within Goldman Sachs Asset Management (Goldman Sachs) provided first lien debt and an equity co-investment to support the acquisitions.
  • The team at Goldman Sachs has been invaluable as we executed this platform investment, said Mike Ciaglia, Partner at Performant.
  • Provider Technology continues to look for best-in-class revenue cycle management and managed service provider software businesses to healthcare customers that would expand its geographic footprint and service capabilities.

Global 3D Metrology Market to Generate a Revenue of $6,647.9 million by 2028, Growing at a CAGR of 7.8% from 2021-2028 [236-Pages] | Says Research Dive

Retrieved on: 
Friday, July 15, 2022
Hardware, Coordinate system, Aerospace, VMM, Software, ODS, Center for Urban and Regional Analysis, CAGR, Drive, CMM, Simulation, Quality control, AOI, Research, 3D, NEW, Reverse engineering, COVID-19, Software maintenance, Growth, Metrology, Construction, Heavy industry, Video game, Oil, Others

NEW YORK, July 15, 2022 /PRNewswire/ -- Research Drive has added a new report to its offering titled, 'Global 3D Metrology Market by Offering (Software, Hardware, and Services), Products (Coordinate Measuring Machine (CMM), Optical Digitizer & Scanner (ODS), Video Measuring Machine (VMM), and 3D Automated Optical Inspection (AOI) System), Application (Quality Control & Inspection, Reverse Engineering, Virtual Simulation, and Others), End-use (Aerospace, Automotive, Medical, Construction & Engineering, Heavy Machinery, and Others), and Regional Analysis (North America, Europe, Asia-Pacific, and LAMEA): Global Opportunity Analysis and Industry Forecast, 2021–2028.'

Key Points: 
  • According to the report, the global 3D metrology market is expected to surpass $6,647.9 million by 2028, growing rapidly at a CAGR of 7.8% during the forecast period 2021-2028.
  • Rising demand for advanced testing technologies and instruments is expected to drive the growth of the market during the forecast period.
  • This factor is predicted to further bolster the growth of the 3D metrology market during the forecast period.
  • High-cost impediments of 3D metrology products is expected to restrict the growth of the 3D metrology market during the forecast period.

Global 3D Metrology Market to Generate a Revenue of $6,647.9 million by 2028, Growing at a CAGR of 7.8% from 2021-2028 [236-Pages] | Says Research Dive

Retrieved on: 
Friday, July 15, 2022
Hardware, Coordinate system, Aerospace, VMM, Software, ODS, Center for Urban and Regional Analysis, CAGR, Drive, CMM, Simulation, Quality control, AOI, Research, 3D, NEW, Reverse engineering, COVID-19, Software maintenance, Growth, Metrology, Construction, Heavy industry, Video game, Oil, Others

NEW YORK, July 15, 2022 /PRNewswire/ -- Research Drive has added a new report to its offering titled, 'Global 3D Metrology Market by Offering (Software, Hardware, and Services), Products (Coordinate Measuring Machine (CMM), Optical Digitizer & Scanner (ODS), Video Measuring Machine (VMM), and 3D Automated Optical Inspection (AOI) System), Application (Quality Control & Inspection, Reverse Engineering, Virtual Simulation, and Others), End-use (Aerospace, Automotive, Medical, Construction & Engineering, Heavy Machinery, and Others), and Regional Analysis (North America, Europe, Asia-Pacific, and LAMEA): Global Opportunity Analysis and Industry Forecast, 2021–2028.'

Key Points: 
  • According to the report, the global 3D metrology market is expected to surpass $6,647.9 million by 2028, growing rapidly at a CAGR of 7.8% during the forecast period 2021-2028.
  • Rising demand for advanced testing technologies and instruments is expected to drive the growth of the market during the forecast period.
  • This factor is predicted to further bolster the growth of the 3D metrology market during the forecast period.
  • High-cost impediments of 3D metrology products is expected to restrict the growth of the 3D metrology market during the forecast period.

Brand Institute Executive, a Former FDA Team Leader, Celebrates 15 Years with Company's Subsidiary, Drug Safety Institute

Retrieved on: 
Thursday, June 23, 2022
Name, FDA, Approximation error, Safety, WHO, U.S. Public Health Service reorganizations of 1966–1973, DSI, Regulation of tobacco by the U.S. Food and Drug Administration, LCDR, Drug Safety, Fire Safety Evaluation System, Health Canada, Brand Institute, AMA, Risk management, Food, EMA, Technical support, OSE, ODS, Division, Medical device, Epidemiology

MIAMI, June 23, 2022 /PRNewswire/ -- Brand Institute , the global leader in pharmaceutical and healthcare-related name development, recently celebrated the 15-year anniversary of former FDA Team Leader, Dr. Nora Roselle, with Brand Institute/Drug Safety Institute.

Key Points: 
  • MIAMI, June 23, 2022 /PRNewswire/ -- Brand Institute , the global leader in pharmaceutical and healthcare-related name development, recently celebrated the 15-year anniversary of former FDA Team Leader, Dr. Nora Roselle, with Brand Institute/Drug Safety Institute.
  • Dr. Roselle joined Drug Safety Institute (DSI) as Managing Director of U.S. Regulatory Affairs in May 2007, and later as Vice President, Global Regulatory Affairs in 2012.
  • Dr. Roselle oversees all U.S. brand nomenclature safety assessments and FDA name submissions.
  • Drug Safety Institute (DSI) is a wholly owned subsidiary of Brand Institute that provides Brand Institute's healthcare clients with industry-leading guidance pertaining to drug name safety, packaging, and labeling.